drugset / Trial / NCT06416787
Safety and Tolerability of IBI355 in Healthy Volunteers
RandomizedParallel-groupSingle-blindTreatment
Summary
This study aims to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of IBI355 in Healthy volunteers. This study also aims to evaluate the anti-Drug antibody after multiple ascending doses of IBI355 in Healthy volunteers.
Timeline
- Start
- 2024-05-20
- Primary completion
- 2025-02-26
- Completion
- 2025-04-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IBI355 | Unknown | 1 mg/kg | — |
| Subject | IBI355 | Unknown | 7.5 mg/kg | — |
| Subject | IBI355 | Unknown | 15 mg/kg | — |
| Subject | IBI355 | Unknown | 30 mg/kg | — |
Indications
No indication recorded.